首页> 外文期刊>ESC Heart Failure >Neutrophil‐to‐lymphocyte ratio and platelet‐to‐lymphocyte ratio as predictors of survival after heart transplantation
【24h】

Neutrophil‐to‐lymphocyte ratio and platelet‐to‐lymphocyte ratio as predictors of survival after heart transplantation

机译:中性粒细胞与淋巴细胞之比和血小板与淋巴细胞之比作为心脏移植术后生存的预测指标

获取原文
           

摘要

Aims The aim of this study was to evaluate whether neutrophil‐to‐lymphocyte ratio (NLR) and platelet‐to‐lymphocyte ratio (PLR) predict outcome in heart failure (HF) patients undergoing heart transplantation (HTX). Methods and results Data from 111 HF patients undergoing HTX 2010–2015 were retrospectively reviewed. NLR and PLR were calculated before HTX, immediately after HTX, and at 6 and 24?hours. Primary endpoint was in‐hospital mortality, and secondary endpoints were 1?year mortality and renal replacement therapy (RRT). Prognostic factors were assessed by multivariate analysis, and the predictive values of NLR and PLR for mortality were compared. The discriminatory performance for predicting in‐hospital mortality was better for NLR [area under the receiver operating characteristic curve (AUC)?=?0.644, 95% confidence interval 0.492–0.797] than for PLR (AUC?=?0.599, 95% confidence interval 0.423–0.776). Best cut‐off value was 2.41 for NLR (sensitivity 86%, specificity 67%) and 92.5 for PLR (sensitivity 86%, specificity 68%). When divided according to best cut‐off value, in‐hospital mortality was significantly higher in the high NLR group (17.5% vs. 3.2%, P ??0.05), but not in the high PLR group (16.5% vs. 6.3%, P ?=?ns). One year mortality was not significantly higher for either group (37.5% vs. 6.5% for NLR; 36.7% vs. 9.4% for PLR, P ?=?ns for both), while RRT was significantly higher in both the NLR and PLR high groups (33.8% vs. 0%; 32.9% vs. 3.1%, respectively, P ??0.001). Multivariate analysis indicated that only high NLR (hazard ratio?=?3.403, P ??0.05) and pre‐transplant diabetes (hazard ratio?=?3.364, P ??0.05) were independent prognostic factors for 1?year mortality. Conclusions High NLR was a predictor for in‐hospital mortality, and an independent prognostic factor for 1?year mortality. Both high NLR and high PLR were predictors for RRT.
机译:目的本研究的目的是评估中性粒细胞与淋巴细胞之比(NLR)和血小板与淋巴细胞之比(PLR)是否可预测接受心脏移植(HTX)的心力衰竭(HF)患者的预后。方法和结果回顾性分析了2010年至2015年接受111例HTX的HF患者的数据。在HTX之前,HTX之后以及6和24小时时计算NLR和PLR。主要终点是住院死亡率,次要终点是1年死亡率和肾脏替代疗法(RRT)。通过多因素分析评估预后因素,并比较NLR和PLR对死亡率的预测值。 NLR [在接受者工作特征曲线下的面积(AUC)?=?0.644,95%置信区间0.492-0.797]方面优于PLR(AUC?=?0.599,95%置信度)区间0.423–0.776)。 NLR的最佳临界值为2.41(敏感性86%,特异性67%)和PLR为92.5(敏感性86%,特异性68%)。如果按最佳临界值划分,高NLR组的院内死亡率显着较高(17.5%比3.2%,P <0.05),而不是高PLR组(16.5%比6.3)。 %,P≥Δns)。两组的一年死亡率均不显着较高(对于NLR,分别为37.5%和6.5%;对于PLR,两者分别为36.7%和9.4%,两者均为P =?ns),而在NLR和PLR中,RRT均显着较高组(分别为33.8%和0%; 32.9%和3.1%,P <0.001)。多因素分析表明,只有高的NLR(危险比== 3.403,P 0.05)和移植前糖尿病(危险比== 3.364,P 0.05)是1年死亡率的独立预后因素。结论高NLR可以预测院内死亡率,并且是1年死亡率的独立预后因素。高NLR和高PLR都是RRT的预测因子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号